Elevance Health Inc Says CMS Released Its 2024 Star Ratings For Medicare Advantage And Medicare Part D Prescription Drug Plans; Pct Of Medicare Advantage Members Of Co Affiliated Health Plans In 4 Star/ Higher-Rated Plans May Drop To About 34%
Portfolio Pulse from Benzinga Newsdesk
Elevance Health Inc has announced that the Centers for Medicare & Medicaid Services (CMS) has released its 2024 Star Ratings for Medicare Advantage and Medicare Part D Prescription Drug Plans. The percentage of Medicare Advantage members of company-affiliated health plans in 4-star or higher-rated plans may drop to about 34%, according to an SEC filing.
October 13, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The CMS 2024 Star Ratings may result in a decrease in the percentage of Elevance Health's Medicare Advantage members in 4-star or higher-rated plans. This could potentially impact the company's reputation and financial performance.
The CMS Star Ratings are a measure of the quality of health plans. A decrease in the percentage of Elevance Health's members in 4-star or higher-rated plans could indicate a decline in the quality of the company's affiliated health plans. This could potentially lead to a decrease in membership, impacting the company's revenues and stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100